Neuroproteomics in neurotrauma
Neurotrauma in the form of traumatic brain injury (TBI) afflicts more Americans annually than Alzheimer's and Parkinson's disease combined, yet few researchers have used neuroproteomics to investigate the underlying complex molecular events that exacerbate TBI. Discussed in this review is...
Saved in:
Published in | Mass spectrometry reviews Vol. 25; no. 3; pp. 380 - 408 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.05.2006
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neurotrauma in the form of traumatic brain injury (TBI) afflicts more Americans annually than Alzheimer's and Parkinson's disease combined, yet few researchers have used neuroproteomics to investigate the underlying complex molecular events that exacerbate TBI. Discussed in this review is the methodology needed to explore the neurotrauma proteome—from the types of samples used to the mass spectrometry identification and quantification techniques available. This neuroproteomics survey presents a framework for large‐scale protein research in neurotrauma, as applied for immediate TBI biomarker discovery and the far‐reaching systems biology understanding of how the brain responds to trauma. Ultimately, knowledge attained through neuroproteomics could lead to clinical diagnostics and therapeutics to lessen the burden of neurotrauma on society. © 2006 Wiley Periodicals, Inc., Mass Spec Rev 25:380–408, 2006 |
---|---|
Bibliography: | istex:4CC7FCD6E97DACB4AE34448B28288D23B9C34F88 ark:/67375/WNG-GZX587QB-Q ArticleID:MAS20073 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-3 ObjectType-Review-1 |
ISSN: | 0277-7037 1098-2787 |
DOI: | 10.1002/mas.20073 |